OTCMKTS:SPHS

Sophiris Bio (SPHS) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$4,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SPHS stock logo

About Sophiris Bio Stock (OTCMKTS:SPHS)

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

SPHS Stock News Headlines

Best Louisiana High Schools
BLTE - Belite Bio, Inc
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Bio-Reference Laboratories
Sophiris Bio Inc. Registered Sh (BFF1.SG)
See More Headlines
Receive SPHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2019
Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:SPHS
Fax
N/A
Employees
2,018
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4,000.00
Optionable
Not Optionable
Beta
1.94
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Randall E. Woods
    President & Chief Executive Officer
  • Peter T. Slover
    Chief Financial & Accounting Officer

SPHS Stock Analysis - Frequently Asked Questions

How were Sophiris Bio's earnings last quarter?

Sophiris Bio, Inc. (OTCMKTS:SPHS) posted its earnings results on Thursday, May, 9th. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.02.

How do I buy shares of Sophiris Bio?

Shares of SPHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SPHS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners